About Natural Capsules Limited
Data last updated: 15 July 2026
Natural Capsules Limited is a public limited company based in Bengaluru, Karnataka, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 20 September 1993, the company has been in operation for over 33 years.
Registered with ROC Bangalore under CIN L85110KA1993PLC014742. Listed on BSE: 524654.
Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹10.41 Cr. It is led by directors including Laxminarayan Moondra and Jyoti Mundra.
Last AGM: 04 August 2025. Financial statements filed for year ended 31 March 2025. Office: Trident Towers 4Th Floor (Level 3) No. 23 100 Feet Road Jaynagar Ii Block, Bengaluru, Karnataka, India – 560011.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹187.2 Cr, a growth of 10.64% compared to the previous year. The net worth stands at ₹234.72 Cr (down 8.73% YoY). Total assets are valued at ₹424.16 Cr (up 1.15% YoY).
The company has a workforce of approximately 172 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Natural Capsules. As per MCA filings, the company has open charges of ₹154.08 Cr and satisfied charges of ₹12.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naturalcapsules.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressTrident Towers 4Th Floor (Level 3) No. 23 100 Feet Road Jaynagar Ii Block, Bengaluru, Karnataka, India – 560011
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Natural Capsules Limited
Natural Capsules Limited has one previous CIN (Corporate Identification Number): U85110KA1993PTC014742. The current CIN is L85110KA1993PLC014742, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110KA1993PLC014742 | Current |
| U85110KA1993PTC014742 | Previous |
Associated Brands with Natural Capsules Limited
Natural Capsules Limited operates one associated brand: Natural Capsules. These brands represent Natural Capsules Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supply chain services for biopharma sector are provided. | naturalcapsules.com |
Competitors & Alternatives of Natural Capsules Limited
Brands and companies operating in the same space as Natural Capsules Limited include Legacy Pharma Solutions, SCHOTT Poonawalla, Ideal Cures and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Legacy Pharma Solutions
|
Contract pharmaceutical packaging company | Earth City, United States, United States | 2003 |
SCHOTT Poonawalla
|
Packaging solutions for pharmaceutical and biotech industries are provided. | Mumbai, India, India | 1990 |
Ideal Cures
|
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms | Mumbai, India, India | 1999 |
Sanner
|
Plastic packaging solutions for pharmaceutical products are manufactured. | Bensheim, Germany, Germany | 1894 |
Cilicant
|
Drugs for the biopharma sector are manufactured and supplied. | Pune, India, India | 2011 |
Nutra-Med Packaging
|
Provider of drugs packaging services | Hanover, United States, United States | 1999 |
Eulysis
|
Diabetes management and lifestyle modification services are provided. | Cambridge, United States, United States | 2010 |
AINIA
|
Pharmaceutical packaging services are provided by AINIA in Spain. | Paterna, Spain, Spain | 1987 |
Business Activity of Natural Capsules Limited
Natural Capsules Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Natural Capsules Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Natural Capsules Limited
Natural Capsules Limited is audited by M/s P Chandrasekar LLP (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s P Chandrasekar LLP (ICAI peer reviewed, certificate valid till 2028-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Natural Capsules Limited
Natural Capsules Limited is currently managed by 8 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Natural Capsules Limited FY 2026 filings available
Natural Capsules Limited reported revenue of ₹187.2 Cr (up 10.64% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹187.2 Cr | ₹169.21 Cr |
| Other Income | ₹1.73 Cr | ₹70.36 Lakh |
| Total Income | ₹188.94 Cr | ₹169.91 Cr |
| Cost of Materials Consumed | ₹103.23 Cr | ₹86.88 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | -₹88.14 Lakh | -₹1.97 Cr |
| Employee Benefit Expense | ₹21 Cr | ₹14.13 Cr |
| Finance Costs | ₹10.95 Cr | ₹6.31 Cr |
| Depreciation & Amortisation | ₹17.14 Cr | ₹9.12 Cr |
| Other Expenses | ₹65.41 Cr | ₹52.65 Cr |
| Total Expenses | ₹216.86 Cr | ₹167.12 Cr |
| Profit Before Exceptional Items & Tax | -₹27.92 Cr | ₹2.79 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | -₹27.92 Cr | ₹2.79 Cr |
| Total Tax Expense | -₹3.26 Cr | ₹2.17 Cr |
| Net Profit | -₹24.66 Cr | ₹61.74 Lakh |
| attributable to Owners | -₹17.07 Cr | - |
| attributable to NCI | -₹7.59 Cr | - |
| Other Comprehensive Income | -₹55,000 | -₹39.01 Lakh |
| Total Comprehensive Income | -₹24.67 Cr | ₹22.73 Lakh |
| EBITDA (computed) | ₹17.2 Lakh | ₹18.22 Cr |
| Basic EPS | ₹-23.84 | ₹0.22 |
| Diluted EPS | ₹-23.78 | ₹0.22 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹424.16 Cr | ₹419.35 Cr |
| Non-current Assets | ₹287.36 Cr | ₹289.76 Cr |
| Current Assets | ₹136.8 Cr | ₹129.59 Cr |
| Property, Plant & Equipment | ₹273.33 Cr | ₹282.33 Cr |
| Inventories | ₹26.33 Cr | ₹25.46 Cr |
| Trade Receivables | ₹71.35 Cr | ₹62.24 Cr |
| Cash & Equivalents | ₹22.03 Lakh | ₹68.89 Lakh |
| Equity (Net Worth) | ₹234.72 Cr | ₹257.16 Cr |
| Equity Share Capital | ₹10.39 Cr | ₹10.34 Cr |
| Borrowings (Non-current) | ₹54.72 Cr | ₹56.4 Cr |
| Borrowings (Current) | ₹59.62 Cr | ₹47.4 Cr |
| Total Debt (computed) | ₹114.34 Cr | ₹103.81 Cr |
| Current Liabilities | ₹132.73 Cr | ₹99.99 Cr |
| Total Liabilities | ₹189.44 Cr | ₹162.19 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹10.92 Cr | ₹26.75 Cr |
| Investing Cash Flow | -₹10.77 Cr | -₹44.48 Cr |
| Financing Cash Flow | -₹62.03 Lakh | ₹16.17 Cr |
| Capital Expenditure | ₹11.53 Cr | ₹44.63 Cr |
| Free Cash Flow (computed) | -₹61.32 Lakh | -₹17.88 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | -₹46.86 Lakh | -₹1.57 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹58.45 Cr | ₹37.75 Cr | ₹45.8 Cr | ₹45.2 Cr | ₹44.97 Cr |
| Other Income | ₹76.4 Lakh | ₹44.79 Lakh | ₹16.13 Lakh | ₹35.85 Lakh | ₹30.43 Lakh |
| Total Income | ₹59.22 Cr | ₹38.19 Cr | ₹45.96 Cr | ₹45.56 Cr | ₹45.27 Cr |
| Cost of Materials Consumed | ₹29.47 Cr | ₹25.34 Cr | ₹24.84 Cr | ₹23.58 Cr | ₹22.95 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹6.01 Cr | -₹6.37 Cr | -₹51.75 Lakh | -₹65,000 | -₹14.29 Lakh |
| Employee Benefit Expense | ₹5.48 Cr | ₹5.73 Cr | ₹5.55 Cr | ₹5.38 Cr | ₹3.71 Cr |
| Finance Costs | ₹2.89 Cr | ₹2.85 Cr | ₹2.68 Cr | ₹2.53 Cr | ₹1.64 Cr |
| Depreciation & Amortisation | ₹4.28 Cr | ₹4.36 Cr | ₹4.29 Cr | ₹4.21 Cr | ₹2.16 Cr |
| Other Expenses | ₹16.16 Cr | ₹15.37 Cr | ₹16.82 Cr | ₹15.93 Cr | ₹14.07 Cr |
| Total Expenses | ₹64.29 Cr | ₹47.28 Cr | ₹53.66 Cr | ₹51.63 Cr | ₹44.38 Cr |
| Profit Before Exceptional Items & Tax | -₹5.08 Cr | -₹9.08 Cr | -₹7.69 Cr | -₹6.06 Cr | ₹89.13 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹5.08 Cr | -₹9.08 Cr | -₹7.69 Cr | -₹6.06 Cr | ₹89.13 Lakh |
| Total Tax Expense | -₹9.97 Lakh | -₹1.97 Cr | -₹70.59 Lakh | -₹48.39 Lakh | ₹37.06 Lakh |
| Net Profit | -₹4.98 Cr | -₹7.12 Cr | -₹6.99 Cr | -₹5.58 Cr | ₹52.07 Lakh |
| attributable to Owners | -₹3.45 Cr | ₹0 | - | - | - |
| attributable to NCI | -₹1.53 Cr | ₹0 | - | - | - |
| Other Comprehensive Income | -₹55,000 | ₹0 | ₹0 | ₹0 | -₹39.01 Lakh |
| Total Comprehensive Income | -₹4.98 Cr | -₹7.12 Cr | -₹6.99 Cr | -₹5.58 Cr | ₹13.06 Lakh |
| EBITDA (computed) | ₹2.09 Cr | -₹1.88 Cr | -₹72.3 Lakh | ₹67.77 Lakh | ₹4.69 Cr |
| Basic EPS | ₹-4.82 | ₹-6.88 | ₹-6.76 | ₹-5.40 | ₹0.13 |
| Diluted EPS | ₹-4.80 | ₹-6.85 | ₹-6.76 | ₹-5.40 | ₹0.13 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Capsules | ₹50.8 Cr | ₹8.92 Cr | ₹181.72 Cr | ₹53.19 Cr |
| API | ₹7.65 Cr | -₹9.35 Cr | ₹242.42 Cr | ₹21.89 Cr |
| Unallocated | ₹0 | ₹0 | ₹0 | ₹0 |
| other | ₹0 | ₹0 | ₹1.94 Lakh | ₹94,000 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Capsules | ₹173.77 Cr | ₹20.82 Cr | - | - |
| API | ₹13.43 Cr | -₹31.33 Cr | - | - |
| Unallocated | ₹0 | ₹0 | - | - |
| other | ₹0 | ₹0 | - | - |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹173.77 Cr | ₹167.94 Cr |
| Other Income | ₹7.65 Cr | ₹4.24 Cr |
| Total Income | ₹181.42 Cr | ₹172.17 Cr |
| Cost of Materials Consumed | ₹87.42 Cr | ₹85.12 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | -₹20.92 Lakh | -₹1.13 Cr |
| Employee Benefit Expense | ₹15.28 Cr | ₹13.74 Cr |
| Finance Costs | ₹5.75 Cr | ₹5.91 Cr |
| Depreciation & Amortisation | ₹8.16 Cr | ₹8.33 Cr |
| Other Expenses | ₹49.95 Cr | ₹50.91 Cr |
| Total Expenses | ₹166.36 Cr | ₹162.88 Cr |
| Profit Before Exceptional Items & Tax | ₹15.07 Cr | ₹9.3 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹15.07 Cr | ₹9.3 Cr |
| Total Tax Expense | ₹3.85 Cr | ₹2.59 Cr |
| Net Profit | ₹11.21 Cr | ₹6.71 Cr |
| Other Comprehensive Income | -₹5.13 Lakh | -₹38.49 Lakh |
| Total Comprehensive Income | ₹11.16 Cr | ₹6.33 Cr |
| EBITDA (computed) | ₹28.98 Cr | ₹23.54 Cr |
| Basic EPS | ₹10.79 | ₹6.12 |
| Diluted EPS | ₹10.79 | ₹6.12 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹296.01 Cr | ₹268.08 Cr |
| Non-current Assets | ₹204.56 Cr | ₹171.46 Cr |
| Current Assets | ₹91.45 Cr | ₹96.62 Cr |
| Property, Plant & Equipment | ₹86.77 Cr | ₹86.86 Cr |
| Inventories | ₹20.3 Cr | ₹21.11 Cr |
| Trade Receivables | ₹61.28 Cr | ₹61.31 Cr |
| Cash & Equivalents | ₹21.56 Lakh | ₹66.8 Lakh |
| Equity (Net Worth) | ₹179.71 Cr | ₹166.32 Cr |
| Equity Share Capital | ₹10.39 Cr | ₹10.34 Cr |
| Borrowings (Non-current) | ₹18.98 Cr | ₹19.99 Cr |
| Borrowings (Current) | ₹39.15 Cr | ₹35.02 Cr |
| Total Debt (computed) | ₹58.12 Cr | ₹55.01 Cr |
| Current Liabilities | ₹90.6 Cr | ₹75.47 Cr |
| Total Liabilities | ₹116.29 Cr | ₹101.76 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹36.16 Cr | ₹18.03 Cr |
| Investing Cash Flow | -₹33.76 Cr | -₹34.37 Cr |
| Financing Cash Flow | -₹2.85 Cr | ₹14.81 Cr |
| Capital Expenditure | ₹9.67 Cr | ₹2.31 Cr |
| Free Cash Flow (computed) | ₹26.49 Cr | ₹15.72 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | -₹45.24 Lakh | -₹1.53 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹50.8 Cr | ₹34.15 Cr | ₹44.58 Cr | ₹44.24 Cr | ₹44.36 Cr |
| Other Income | ₹2.13 Cr | ₹2.11 Cr | ₹1.73 Cr | ₹1.69 Cr | ₹1.55 Cr |
| Total Income | ₹52.93 Cr | ₹36.25 Cr | ₹46.31 Cr | ₹45.93 Cr | ₹45.91 Cr |
| Cost of Materials Consumed | ₹21.56 Cr | ₹20.94 Cr | ₹22.82 Cr | ₹22.1 Cr | ₹22.13 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹4.16 Cr | -₹4.69 Cr | -₹32.46 Lakh | ₹63.97 Lakh | ₹21.46 Lakh |
| Employee Benefit Expense | ₹4.06 Cr | ₹3.91 Cr | ₹3.7 Cr | ₹3.61 Cr | ₹3.58 Cr |
| Finance Costs | ₹1.49 Cr | ₹1.45 Cr | ₹1.45 Cr | ₹1.36 Cr | ₹1.52 Cr |
| Depreciation & Amortisation | ₹2.06 Cr | ₹2.09 Cr | ₹2.02 Cr | ₹1.99 Cr | ₹1.94 Cr |
| Other Expenses | ₹12.16 Cr | ₹12.09 Cr | ₹12.94 Cr | ₹12.75 Cr | ₹13.38 Cr |
| Total Expenses | ₹45.49 Cr | ₹35.79 Cr | ₹42.61 Cr | ₹42.46 Cr | ₹42.78 Cr |
| Profit Before Exceptional Items & Tax | ₹7.43 Cr | ₹45.84 Lakh | ₹3.7 Cr | ₹3.48 Cr | ₹3.13 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹7.43 Cr | ₹45.84 Lakh | ₹3.7 Cr | ₹3.48 Cr | ₹3.13 Cr |
| Total Tax Expense | ₹1.91 Cr | ₹9.61 Lakh | ₹88.73 Lakh | ₹95.49 Lakh | ₹50.56 Lakh |
| Net Profit | ₹5.52 Cr | ₹36.23 Lakh | ₹2.81 Cr | ₹2.52 Cr | ₹2.63 Cr |
| Other Comprehensive Income | -₹5.13 Lakh | ₹0 | ₹0 | ₹0 | -₹38.49 Lakh |
| Total Comprehensive Income | ₹5.47 Cr | ₹36.23 Lakh | ₹2.81 Cr | ₹2.52 Cr | ₹2.24 Cr |
| EBITDA (computed) | ₹10.98 Cr | ₹4.01 Cr | ₹7.17 Cr | ₹6.83 Cr | ₹6.6 Cr |
| Basic EPS | ₹5.33 | ₹0.35 | ₹2.72 | ₹2.44 | ₹2.17 |
| Diluted EPS | ₹5.32 | ₹0.35 | ₹2.72 | ₹0.00 | ₹2.17 |
Shareholding Pattern of Natural Capsules Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 51.04%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 48.96% of Natural Capsules Limited. The company had 8,850 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Feb 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 51.04% | 51.26% | 51.26% | 51.26% | 51.21% | 51.14% |
| Public | 48.96% | 48.74% | 48.74% | 48.74% | 48.79% | 48.86% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 51.04% | 51.21% |
| Public | 48.96% | 48.79% |
| Promoter change (YoY, %pts) | -0.17 | - |
Board & Governance of Natural Capsules Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Natural Capsules Limited has 8 directors - 3 independent and 3 executive. The board is chaired by Tekkar Yashwanth Prabhu.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Tekkar Yashwanth Prabhu | Non-Executive - Independent Director · Chairperson | 2024-06-19 | 1 |
| Sunil Laxminarayana Mundra | Executive Director · MD | 2011-06-01 | 1 |
| Sushil Kumar Mundra | Non-Executive - Non Independent Director | 1993-09-20 | 1 |
| Sathyanarayana Mundra | Executive Director | 1993-09-20 | 1 |
| Jyoti Mundra | Non-Executive - Non Independent Director | 2015-03-30 | 1 |
| Pramod Kasat | Non-Executive - Independent Director | 2019-05-30 | 4 |
| Laxminarayan Moondra | Executive Director | 2011-06-01 | 1 |
| Shirish Gundopant Belapure | Non-Executive - Independent Director | 2022-08-10 | 4 |
| Committee | Members |
|---|---|
| Audit Committee | Tekkar Yashwanth Prabhu (Chairperson), Pramod Kasat, Shirish Gundopant Belapure, Sunil Laxminarayana Mundra |
| Nomination and remuneration committee | Shirish Gundopant Belapure (Chairperson), Tekkar Yashwanth Prabhu, Pramod Kasat |
| Stakeholders Relationship Committee | Laxminarayan Moondra, Sunil Laxminarayana Mundra, Shirish Gundopant Belapure (Chairperson) |
| Corporate Social Responsibility Committee | Pramod Kasat (Chairperson), Sushil Kumar Mundra, Sunil Laxminarayana Mundra |
Group Structure of Natural Capsules Limited
Natural Capsules Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Natural Capsules Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Natural Biogenex Private Limited | U24239KA2020PTC137602 | - |
| Natural Phyto Pharma Private Limited | U73200KA2018PTC117070 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Natural Capsules Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2026 | Hdfc Bank Limited | ₹3 Cr | Open |
| 30 Jul 2025 | Others | ₹5 Cr | Open |
| 06 Apr 2022 | State Bank of India | ₹40 Cr | Open |
| 27 Oct 2021 | Hdfc Bank Limited | ₹40 Cr | Open |
| 11 Oct 2021 | Hdfc Bank Limited | ₹36.11 Cr | Open |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Natural Capsules Limited
Natural Capsules Limited has a workforce of 172 employees as of Apr 06, 2024.
Employee and EPFO history for Natural Capsules Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Natural Capsules Limited
GST registrations and filing compliance for Natural Capsules Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Natural Capsules Limited
Credit ratings, litigation, and regulatory alerts for Natural Capsules Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Natural Capsules Limited
MSME payment history for Natural Capsules Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Natural Capsules Limited
Corporate group structure for Natural Capsules Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Natural Capsules Limited
MCA filings and documents for Natural Capsules Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Natural Capsules Limited
Recent News on Natural Capsules Limited
Frequently Asked Questions about Natural Capsules Limited
Natural Capsules Limited is an active public limited company in the pharma sector based in Bengaluru, Karnataka, India. It was incorporated on 20 September 1993 (33+ years old) and is registered under CIN L85110KA1993PLC014742. Listed on BSE: 524654. The company has 172 employees.
Natural Capsules Limited reported revenue of ₹187.2 Cr for FY 2026 (up 10.64% YoY) based on consolidated NSE filings.
The current directors of Natural Capsules Limited are:
- Laxminarayan Moondra - Whole-Time Director
- Jyoti Mundra - Director
- Pramod Kasat - Director
- Sushil Kumar Mundra - Director
- Sunil Laxminarayana Mundra - Managing Director
- Sathyanarayana Mundra - Whole-Time Director
- Shirish Gundopant Belapure - Director
- Tekkar Yashwanth Prabhu - Director
The primary industry of Natural Capsules Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Natural Capsules Limited is listed on BSE with code 524654.
Natural Capsules Limited can be reached at the registered office: Trident Towers 4Th Floor Level 3 No. 23 100 Feet Road Jaynagar Ii Block, Bengaluru, Karnataka, India – 560011, or through the website naturalcapsules.com.